ID   GMPR2_HUMAN             Reviewed;         348 AA.
AC   Q9P2T1; D3DS66; Q567T0; Q6IAJ8; Q86T14;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 144.
DE   RecName: Full=GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};
DE            Short=GMPR 2 {ECO:0000255|HAMAP-Rule:MF_03195};
DE            EC=1.7.1.7 {ECO:0000255|HAMAP-Rule:MF_03195};
DE   AltName: Full=Guanosine 5'-monophosphate oxidoreductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};
DE            Short=Guanosine monophosphate reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195};
GN   Name=GMPR2 {ECO:0000255|HAMAP-Rule:MF_03195};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=12009299; DOI=10.1016/S1357-2725(02)00024-9;
RA   Deng Y., Wang Z., Ying K., Gu S., Ji C., Huang Y., Gu X., Wang Y.,
RA   Xu Y., Li Y., Xie Y., Mao Y.;
RT   "NADPH-dependent GMP reductase isoenzyme of human (GMPR2). Expression,
RT   purification, and kinetic properties.";
RL   Int. J. Biochem. Cell Biol. 34:1035-1050(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12669231; DOI=10.1007/s00432-002-0413-7;
RA   Zhang J., Zhang W., Zou D., Chen G., Wan T., Zhang M., Cao X.;
RT   "Cloning and functional characterization of GMPR2, a novel human
RT   guanosine monophosphate reductase, which promotes the monocytic
RT   differentiation of HL-60 leukemia cells.";
RL   J. Cancer Res. Clin. Oncol. 129:76-83(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Okaze H., Hayashi A., Kozuma S., Saito T.;
RT   "A novel protein related to guanosine monophosphate reductase.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta, and T-cell;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-291, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH GMP, CATALYTIC
RP   ACTIVITY, FUNCTION, ACTIVE SITE, SUBUNIT, AND MUTAGENESIS OF CYS-186.
RX   PubMed=16359702; DOI=10.1016/j.jmb.2005.11.047;
RA   Li J., Wei Z., Zheng M., Gu X., Deng Y., Qiu R., Chen F., Ji C.,
RA   Gong W., Xie Y., Mao Y.;
RT   "Crystal structure of human guanosine monophosphate reductase 2
RT   (GMPR2) in complex with GMP.";
RL   J. Mol. Biol. 355:980-988(2006).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 10-341 IN COMPLEX WITH IMP
RP   AND NADP, CATALYTIC ACTIVITY, FUNCTION, ACTIVE SITE, SUBUNIT, AND
RP   MUTAGENESIS OF CYS-186; THR-188 AND GLU-289.
RX   PubMed=22037469; DOI=10.1038/nchembio.693;
RA   Patton G.C., Stenmark P., Gollapalli D.R., Sevastik R., Kursula P.,
RA   Flodin S., Schuler H., Swales C.T., Eklund H., Himo F., Nordlund P.,
RA   Hedstrom L.;
RT   "Cofactor mobility determines reaction outcome in the IMPDH and GMPR
RT   (beta-alpha)8 barrel enzymes.";
RL   Nat. Chem. Biol. 7:950-958(2011).
CC   -!- FUNCTION: Catalyzes the irreversible NADPH-dependent deamination
CC       of GMP to IMP. It functions in the conversion of nucleobase,
CC       nucleoside and nucleotide derivatives of G to A nucleotides, and
CC       in maintaining the intracellular balance of A and G nucleotides
CC       (PubMed:12009299, PubMed:12669231, PubMed:16359702,
CC       PubMed:22037469). Plays a role in modulating cellular
CC       differentiation (PubMed:12669231). {ECO:0000255|HAMAP-
CC       Rule:MF_03195, ECO:0000269|PubMed:12009299,
CC       ECO:0000269|PubMed:12669231, ECO:0000269|PubMed:16359702,
CC       ECO:0000269|PubMed:22037469}.
CC   -!- CATALYTIC ACTIVITY: Inosine 5'-phosphate + NH(3) + NADP(+) =
CC       guanosine 5'-phosphate + NADPH. {ECO:0000255|HAMAP-Rule:MF_03195,
CC       ECO:0000269|PubMed:12009299, ECO:0000269|PubMed:16359702,
CC       ECO:0000269|PubMed:22037469}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_03195,
CC       ECO:0000269|PubMed:16359702, ECO:0000269|PubMed:22037469}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P2T1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2T1-2; Sequence=VSP_041459;
CC       Name=3;
CC         IsoId=Q9P2T1-3; Sequence=VSP_054585;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle,
CC       kidney, brain, liver, prostate, spleen, placenta, testis and
CC       ovary. Low expression in colon, thymus and peripheral blood
CC       leukocytes. {ECO:0000269|PubMed:12009299,
CC       ECO:0000269|PubMed:12669231}.
CC   -!- SIMILARITY: Belongs to the IMPDH/GMPR family. GuaC type 1
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03195}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF419346; AAN32701.1; -; mRNA.
DR   EMBL; AF135159; AAG09132.1; -; mRNA.
DR   EMBL; AB032903; BAA93080.1; -; mRNA.
DR   EMBL; BX161436; CAD61908.1; -; mRNA.
DR   EMBL; BX247993; CAD62327.1; -; mRNA.
DR   EMBL; CR457156; CAG33437.1; -; mRNA.
DR   EMBL; AL096870; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW66051.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66053.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66054.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66056.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66057.1; -; Genomic_DNA.
DR   EMBL; BC008021; AAH08021.2; -; mRNA.
DR   EMBL; BC009832; AAH09832.1; -; mRNA.
DR   EMBL; BC093039; AAH93039.1; -; mRNA.
DR   CCDS; CCDS41935.1; -. [Q9P2T1-1]
DR   CCDS; CCDS45087.1; -. [Q9P2T1-2]
DR   CCDS; CCDS61419.1; -. [Q9P2T1-3]
DR   RefSeq; NP_001002000.1; NM_001002000.2. [Q9P2T1-1]
DR   RefSeq; NP_001002001.1; NM_001002001.2. [Q9P2T1-1]
DR   RefSeq; NP_001002002.1; NM_001002002.2. [Q9P2T1-1]
DR   RefSeq; NP_001269950.1; NM_001283021.1.
DR   RefSeq; NP_001269951.1; NM_001283022.1.
DR   RefSeq; NP_001269952.1; NM_001283023.1. [Q9P2T1-3]
DR   RefSeq; NP_057660.2; NM_016576.4. [Q9P2T1-2]
DR   UniGene; Hs.368855; -.
DR   PDB; 2A7R; X-ray; 3.00 A; A/B/C/D=1-348.
DR   PDB; 2BZN; X-ray; 2.15 A; A/B/C/D/E/F/G/H=10-341.
DR   PDB; 2C6Q; X-ray; 1.70 A; A/B/C/D/E/F/G/H=10-341.
DR   PDBsum; 2A7R; -.
DR   PDBsum; 2BZN; -.
DR   PDBsum; 2C6Q; -.
DR   ProteinModelPortal; Q9P2T1; -.
DR   SMR; Q9P2T1; -.
DR   BioGrid; 119443; 7.
DR   IntAct; Q9P2T1; 2.
DR   STRING; 9606.ENSP00000392859; -.
DR   iPTMnet; Q9P2T1; -.
DR   PhosphoSitePlus; Q9P2T1; -.
DR   BioMuta; GMPR2; -.
DR   DMDM; 25008511; -.
DR   EPD; Q9P2T1; -.
DR   MaxQB; Q9P2T1; -.
DR   PaxDb; Q9P2T1; -.
DR   PeptideAtlas; Q9P2T1; -.
DR   PRIDE; Q9P2T1; -.
DR   DNASU; 51292; -.
DR   Ensembl; ENST00000355299; ENSP00000347449; ENSG00000100938. [Q9P2T1-1]
DR   Ensembl; ENST00000399440; ENSP00000382369; ENSG00000100938. [Q9P2T1-1]
DR   Ensembl; ENST00000420554; ENSP00000392859; ENSG00000100938. [Q9P2T1-2]
DR   Ensembl; ENST00000456667; ENSP00000405743; ENSG00000100938. [Q9P2T1-3]
DR   Ensembl; ENST00000559836; ENSP00000453299; ENSG00000100938. [Q9P2T1-1]
DR   GeneID; 51292; -.
DR   KEGG; hsa:51292; -.
DR   UCSC; uc001wnr.5; human. [Q9P2T1-1]
DR   CTD; 51292; -.
DR   DisGeNET; 51292; -.
DR   GeneCards; GMPR2; -.
DR   HGNC; HGNC:4377; GMPR2.
DR   HPA; HPA000904; -.
DR   HPA; HPA067884; -.
DR   HPA; HPA068782; -.
DR   MIM; 610781; gene.
DR   neXtProt; NX_Q9P2T1; -.
DR   OpenTargets; ENSG00000100938; -.
DR   PharmGKB; PA28762; -.
DR   eggNOG; KOG2550; Eukaryota.
DR   eggNOG; COG0516; LUCA.
DR   GeneTree; ENSGT00530000062923; -.
DR   HOGENOM; HOG000165756; -.
DR   HOVERGEN; HBG051744; -.
DR   InParanoid; Q9P2T1; -.
DR   KO; K00364; -.
DR   PhylomeDB; Q9P2T1; -.
DR   TreeFam; TF300378; -.
DR   BRENDA; 1.7.1.7; 2681.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   ChiTaRS; GMPR2; human.
DR   EvolutionaryTrace; Q9P2T1; -.
DR   GenomeRNAi; 51292; -.
DR   PRO; PR:Q9P2T1; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100938; -.
DR   CleanEx; HS_GMPR2; -.
DR   ExpressionAtlas; Q9P2T1; baseline and differential.
DR   Genevisible; Q9P2T1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:1902560; C:GMP reductase complex; IEA:UniProtKB-EC.
DR   GO; GO:0003920; F:GMP reductase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046037; P:GMP metabolic process; IDA:UniProtKB.
DR   GO; GO:0006144; P:purine nucleobase metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   CDD; cd00381; IMPDH; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00596; GMP_reduct_type1; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR005993; GMPR.
DR   InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS.
DR   InterPro; IPR001093; IMP_DH_GMPRt.
DR   Pfam; PF00478; IMPDH; 1.
DR   PIRSF; PIRSF000235; GMP_reductase; 1.
DR   TIGRFAMs; TIGR01305; GMP_reduct_1; 1.
DR   PROSITE; PS00487; IMP_DH_GMP_RED; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Metal-binding; NADP; Oxidoreductase; Polymorphism; Potassium;
KW   Purine metabolism; Reference proteome.
FT   CHAIN         1    348       GMP reductase 2.
FT                                /FTId=PRO_0000093726.
FT   NP_BIND      26     27       NADP; shared with neighboring subunit.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   NP_BIND     129    131       NADP. {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   NP_BIND     180    181       NADP. {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   NP_BIND     285    286       NADP. {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   NP_BIND     314    317       NADP; shared with neighboring subunit.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   REGION      219    221       GMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03195}.
FT   REGION      242    243       GMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03195}.
FT   REGION      268    270       GMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03195}.
FT   REGION      286    290       GMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03195}.
FT   ACT_SITE    186    186       Thioimidate intermediate.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195}.
FT   ACT_SITE    188    188       Proton donor/acceptor.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195}.
FT   METAL       181    181       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195}.
FT   METAL       183    183       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195}.
FT   METAL       186    186       Potassium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195}.
FT   METAL       189    189       Potassium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03195}.
FT   BINDING      78     78       NADP. {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   BINDING     269    269       NADP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03195,
FT                                ECO:0000269|PubMed:22037469}.
FT   MOD_RES     291    291       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1      1       M -> MTSCLPALRFIATPRLSAM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041459.
FT   VAR_SEQ      70     97       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_054585.
FT   VARIANT     242    242       G -> D (in dbSNP:rs34354104).
FT                                /FTId=VAR_049602.
FT   MUTAGEN     186    186       C->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:16359702,
FT                                ECO:0000269|PubMed:22037469}.
FT   MUTAGEN     188    188       T->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:22037469}.
FT   MUTAGEN     289    289       E->Q: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:22037469}.
FT   CONFLICT     91     91       Q -> R (in Ref. 5; CAG33437).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       S -> G (in Ref. 5; CAG33437).
FT                                {ECO:0000305}.
FT   CONFLICT    223    223       S -> N (in Ref. 5; CAG33437).
FT                                {ECO:0000305}.
FT   STRAND        3      9       {ECO:0000244|PDB:2A7R}.
FT   HELIX        12     14       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       15     17       {ECO:0000244|PDB:2C6Q}.
FT   HELIX        27     29       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       34     37       {ECO:0000244|PDB:2C6Q}.
FT   TURN         39     41       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       44     47       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       50     52       {ECO:0000244|PDB:2C6Q}.
FT   TURN         56     58       {ECO:0000244|PDB:2C6Q}.
FT   HELIX        61     69       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       73     75       {ECO:0000244|PDB:2C6Q}.
FT   HELIX        82     91       {ECO:0000244|PDB:2C6Q}.
FT   HELIX        93     95       {ECO:0000244|PDB:2C6Q}.
FT   STRAND       99    103       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       107    119       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      125    129       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       136    148       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      152    159       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       162    170       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      174    178       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       188    192       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       198    211       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      215    220       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       225    233       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      237    242       {ECO:0000244|PDB:2C6Q}.
FT   TURN        243    247       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      248    251       {ECO:0000244|PDB:2A7R}.
FT   STRAND      255    258       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      261    267       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      269    271       {ECO:0000244|PDB:2A7R}.
FT   HELIX       272    278       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      279    281       {ECO:0000244|PDB:2C6Q}.
FT   TURN        283    285       {ECO:0000244|PDB:2A7R}.
FT   STRAND      286    288       {ECO:0000244|PDB:2A7R}.
FT   STRAND      292    296       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       301    319       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       324    326       {ECO:0000244|PDB:2C6Q}.
FT   HELIX       327    330       {ECO:0000244|PDB:2C6Q}.
FT   STRAND      333    335       {ECO:0000244|PDB:2C6Q}.
SQ   SEQUENCE   348 AA;  37874 MW;  E7812A754C433E51 CRC64;
     MPHIDNDVKL DFKDVLLRPK RSTLKSRSEV DLTRSFSFRN SKQTYSGVPI IAANMDTVGT
     FEMAKVLCKF SLFTAVHKHY SLVQWQEFAG QNPDCLEHLA ASSGTGSSDF EQLEQILEAI
     PQVKYICLDV ANGYSEHFVE FVKDVRKRFP QHTIMAGNVV TGEMVEELIL SGADIIKVGI
     GPGSVCTTRK KTGVGYPQLS AVMECADAAH GLKGHIISDG GCSCPGDVAK AFGAGADFVM
     LGGMLAGHSE SGGELIERDG KKYKLFYGMS SEMAMKKYAG GVAEYRASEG KTVEVPFKGD
     VEHTIRDILG GIRSTCTYVG AAKLKELSRR TTFIRVTQQV NPIFSEAC
//
